Alnylam Pharmaceuticals | ALNY

Aktienkurs
215.12
Täglich Wechseln
-1.00 -0.46%
Monatlich
-33.50%
Jährlich
-50.99%
Q3 Prognose
201.16

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-10-29 FY2026Q3 AM 1.97 2.90
2026-07-30 FY2026Q2 AM 1.84 1.61 0.32
2026-04-30 FY2026Q1 AM 1.99 0.99 -0.01
2026-02-12 FY2025Q4 AM 1.25 1.27 0.06
2025-10-30 FY2025Q3 AM 2.90 0.27 -0.50



Preis Chg Tag Jahr Datum
Takeda 5,540.00 115.00 2.12% 29.89% 2026-08-07
Acadia Pharmaceuticals 28.94 0.49 1.72% 17.64% 2026-08-07
Agios Pharmaceuticals 31.87 -0.08 -0.25% -10.88% 2026-08-07
Alnylam Pharmaceuticals 215.12 -1.00 -0.46% -50.99% 2026-08-07
Amgen 406.67 1.82 0.45% 41.09% 2026-08-07
Arrowhead Research 86.88 1.05 1.22% 429.11% 2026-08-07
Tectonic Therapeutic 30.80 0.58 1.92% 38.05% 2026-08-07
BioCryst Pharmaceuticals 9.44 0.14 1.45% 13.67% 2026-08-07
BioMarin Pharmaceutical 62.92 1.46 2.38% 9.75% 2026-08-07
Incyte 120.41 2.03 1.71% 53.60% 2026-08-07

Preis Tag Jahr Datum
USND 26691 342.26 1.30% 24.43% 2026-08-07